glp-1 therapy for Patients with Obesity Different GLP-1 therapies could be

In SURMOUNT-1, a study in 2,539 adults with obesity, or excess weight and weight-related medical problems not including diabetes, people taking Zepbound as an adjunct to diet and exercise experienced substantial weight loss compared with placebo at 72 weeks

These efforts, along with implementing diet and lifestyle changes, will provide the most effective and sustainable outcomes and help inform the decision of whether to use medications or not.

Peptide therapy offers a safer, more affordable alternative with a wider therapeutic index

This therapy supports metabolic balance without introducing synthetic hormones

Evidence suggests the strongest effects appear in individuals with elevated metabolic burden